<h2 id="what-is-ketorolac">What is Ketorolac?</h2>
<ul>
  <li>Nonsteroidal anti-inflammatory drug used primarily for short term, acute pain management.</li>
</ul>
<h2 id="mechanism-of-action-">Mechanism of Action <sup id="fnref:1" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup></h2>
<ul>
  <li>COX-1 and COX-2 inhibitor
    <ul>
      <li>COX-1: involved in platelet aggregation, gastric mucosa, vascular endothelium</li>
      <li>COX-2: converts arachadonic acid -&gt; prostaglandins -&gt; inflammation. Inhibition provides analgesic and anti-inflmmatory properties.</li>
    </ul>
  </li>
  <li>Rapidly absorbed after oral administration. Binds to plasma proteins and is metabolized in the liver. Metabolites excreted mainly by the kidney.</li>
  <li>Half-life: 5-6 hours.</li>
</ul>
<h2 id="dosage">Dosage</h2>
<ul>
  <li>15 - 30 mg PO/IV every 6 hours. Ceiling effect exists above 15 mg.</li>
  <li>Pediatrics 0.5 mg/kg PO/IV every 6 hours</li>
</ul>
<h2 id="indications">Indications</h2>
<ul>
  <li>
    <table>
      <tbody>
        <tr>
          <td>Analgesia (see [[Pain Management</td>
          <td>Pain Management]])</td>
        </tr>
      </tbody>
    </table>
  </li>
</ul>
<h2 id="contraindications-3">Contraindications [^3]</h2>
<ul>
  <li>Renal insufficiency</li>
  <li>Pregnancy (risks premature ductus arteriosus)</li>
  <li>Bleeding disorders</li>
  <li>Surgical concerns of bone, wound or anastomosis</li>
  <li>peptic ulcer</li>
</ul>
<h2 id="references">References</h2>
<div class="footnotes" role="doc-endnotes">
  <ol>
    <li id="fn:1" role="doc-endnote">
      <p>Mahmoodi, N., Patel, P., Kim, P. (2024, February 28). <em>Ketorolac</em>. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK545172/Â <a href="#fnref:1" class="reversefootnote" role="doc-backlink">&#8617;</a></p>
    </li>
  </ol>
</div>